Joel Baglole

Joel Baglole

InvestorPlace Contributor

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

Bluebird Bio (BLUE) Stock Is in Focus Following FDA Approval

By Joel Baglole, InvestorPlace Contributor

The Boston-based biotech company has secured FDA approval for one of its gene therapies. Let's take a closer look at BLUE stock.

7 Stocks Reporting Earnings the Week of Sept. 19

By Joel Baglole, InvestorPlace Contributor

These companies are the final ones to report financial results for the April-through-June period and could move markets in coming days.

3 Housing Stocks to Sell Now

By Joel Baglole, InvestorPlace Contributor

The U.S. housing market is set to cool in 2022 and beyond. These are three housing stocks to sell ahead of time.

Why Railroad Stocks UNP, CSX, NSC Are Up Today

By Joel Baglole, InvestorPlace Contributor

A national rail strike that threatened to cost the U.S. economy $2 billion has been narrowly averted, sending railroad stocks higher.

7 Dividend Stock Picks to Beat the September Market Slump

By Joel Baglole, InvestorPlace Contributor

In the current market downturn, investors, particularly those close to retirement, are searching for safe harbors. Protecting savings while earning income is of paramount importance. This is where dividend stocks come into play.

Load More